Publications by authors named "Paul Maroni"

Claim this Profile
O
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.
David E Crawford, David Albala, Marc B Garnick, Andrew W Hahn, Paul Maroni

Can J Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth Kessler, Paul Maroni

JCO Oncol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer.
Komal Raina, Kushal Kandhari, Rama Kant, Ram Raj Prasad, Neha Mishra, Paul Maroni

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, Geoffrey Box, Sigrid V Carlsson, Paul Maroni

J Natl Compr Canc Netw· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifocal Paraganglioma in Teenager Presenting With Hypertension.
Kristen M Meier, Mariana L Meyers, Lauren Fishbein, Paul D Maroni, Nicholas G Cost

Urology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model.
Komal Raina, Kushal Kandhari, Anil K Jain, Kameswaran Ravichandran, Paul Maroni

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.
Komal Raina, Rama Kant, Ram R Prasad, Kushal Kandhari, Munendra Tomar, Paul Maroni

Mol Carcinog· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer.
Lakshmipathi Khandrika, Rachel Lieberman, Sweaty Koul, Binod Kumar, Paul Maroni

Oncogene· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage-specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis.
Ram R Prasad, Komal Raina, Neha Mishra, Munendra S Tomar, Robin Kumar, Paul Maroni

Mol Carcinog· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
Rodrigo Rodrigues Pessoa, Jeffrey C Morrison, Badrinath Konety, Boris Gershman, Paul Maroni

Urol Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF.
Thomas R Johnson, Sweaty Koul, Binod Kumar, Lakshmipathi Khandrika, Sarah Venezia, Paul D Maroni

Mol Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Median Lobe Urethral Embolus After Focal Ablation of Gleason 7 Prostate Cancer.
Alan Makedon, Paul Maroni

Oncology (Williston Park)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of robotic and open radical prostatectomy.
Rodrigo Rodrigues Pessoa, Paul Maroni, Janet Kukreja, Simon P Kim

Transl Androl Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Approach to Small Unilateral Testicular Nodules-Can We Reliably Predict Tumor Histology Based on Size?
Rodrigo R Pessoa, Michael A Maccini, Brian T Caldwell, Paul D Maroni, Nicholas G Cost

Urol Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tips to start an MR-US fusion biopsy program.
Alison Sheridan, Paul Maroni, Nayana U Patel

Abdom Radiol (NY)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial.
John L Gore, Marguerite du Plessis, Jingbin Zhang, Darlene Dai, Darby J S Thompson, Paul Maroni

Pract Radiat Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Paul Maroni

J Urol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of high-grade prostate cancer risk using prostate cancer biomarkers.
Whitney N Stanton, E David Crawford, Paul B Arangua, Francisco G La Rosa, Adrie van Bokhoven, Paul Maroni

Can J Urol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Hospital Altitude and Postoperative Infectious Complications After Major Operations.
Davis M Aasen, Cole Wiedel, Paul Maroni, Mark E Cohen, Xiangju Meng

High Alt Med Biol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
Boris Gershman, Paul Maroni, Jon C Tilburt, Robert J Volk, Badrinath Konety

World J Urol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
67-year-old Male with Prostatic Stromal Tumor of Uncertain Malignant Potential.
Luke Bidikov, Paul Maroni, Simon Kim, E David Crawford

Oncology (Williston Park)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells.
Alpna Tyagi, Sushil Kumar, Komal Raina, Michael F Wempe, Paul D Maroni

Mol Carcinog· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retroperitoneal Lymph Node Dissection as an Alternative Treatment Strategy for Low Volume, Clinical Stage II Testicular Seminoma: A Survey of Patients and Providers.
Jason C Warncke, Amanda F Saltzman, Paul D Maroni, Siamak Daneshmand, Nicholas G Cost

Urol Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Elizabeth R Kessler, Lih-Jen Su, Dexiang Gao, Kathleen C Torkko, Michael Wacker, Paul Maroni

Integr Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification.
Tyler P Robin, Paul D Maroni, Bennett B Chin, Francisco G La Rosa, Brandon Bernard

Oncology (Williston Park)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis